As of November 2024 BioCryst Pharmaceuticals has a market cap of A$2.44 Billion. This makes BioCryst Pharmaceuticals the world's 4706th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Nov 9th, 2024 the market cap of BioCryst Pharmaceuticals was reported to be: